TERUMO CORP revenue for the last year amounted to 820.21 B JPY, the most of which — 480.61 B JPY — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 397.13 B JPY. The greatest contribution to the revenue figure was made by United States — last year it brought TERUMO CORP 246.13 B JPY, and the year before that — 191.41 B JPY.